After passing some regulations in 2024, Iowa state lawmakers are this year once again considering legislation that would ...

Direct-to-store model (delivering drugs directly to each retailer’s stores) of distributors are increasingly becoming more popular among retailers (represents 93% of sales in 2017, up from 74% in 2007 ...

Cardinal's pharmaceutical and specialty solutions segment distributes branded, generic, and specialty drugs and over-the-counter healthcare and consumer products. Cardinal plays a central role in the ...

Evercore ISI has updated its outlook on CVS Health (NYSE:CVS) shares, raising the price target from $60.00 to $65.00 while ...

CVS Health's poor 2024 performance was driven by negative macro and micro factors. Investors became too pessimistic about the company's forward prospects. A new CEO is a catalyst. Despite weak ...

Our role in the US health system is to fight back against pharma price gouging, and CVS Caremark has a long track record of making specialty drugs more affordable. "For the 2023 calendar year ...

Plan sponsors’ spending on specialty generics rose by 21% yearly for commercial claims between 2017-2021, with patients paying $297 million. Get Wall Street's Hottest Chart Every Morning The ...

The report examines the impact of PBMs (specifically CVS Caremark, Express Scripts and Optum Rx) on specialty generic ... and the median out-of-pocket payment for these patients was $5.” ...

The nation’s three largest pharmacy benefit managers (PBMs) made significant markups to “lifesaving” medications at pharmacies they owned, the Federal Trade Commission said Tuesday, Jan. 14. The ...

The nation’s three largest PBMs – CVS Health’s ... the median out-of-pocket payment for these patients was $5.” Caremark said the agency “cherry-picked specialty generic outliers ...

The report specifically looked at the business practices of the Caremark Rx, Express Scripts and OptumRx, which are in turn owned by CVS Health ... the prices of many specialty generic drugs ...